Search This Blog

Monday, August 3, 2020

Ligand Pharmaceuticals beats on revenue

Ligand Pharmaceuticals (NASDAQ:LGND): Q2 Non-GAAP EPS of $1.00; GAAP EPS of $1.32.
Revenue of $41.42M (+65.7% Y/Y) beats by $11.46M.
Press Release


Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)